Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
O-I Glass | OI | 3. jui 2024 | 12.34 | -2.76 |
Oak Valley Bancorp | OVLY | 3. jui 2024 | 23.32 | -2.10 |
Oak Woods Acquisition | OAKU | 3. jui 2024 | 10.79 | 0.00 |
Oaktree Capital A Pref | OAK-A | 3. jui 2024 | 21.44 | -0.28 |
Oaktree Capital Group B Pref | OAK-B | 3. jui 2024 | 21.23 | +0.52 |
Oaktree Specialty | OCSL | 3. jui 2024 | 19.67 | +0.77 |
Oatly ADR | OTLY | 3. jui 2024 | 1.07 | -1.83 |
Oblong | OBLG | 3. jui 2024 | 0.25 | +16.25 |
OCA Acquisition A | OCAX | 3. jui 2024 | 11.11 | +0.54 |
Occidental Petroleum | OXY | 3. jui 2024 | 60.57 | -3.09 |
Ocean Biomedical | OCEA | 3. jui 2024 | 1.60 | +8.84 |
Ocean Power Technologies | OPTT | 3. jui 2024 | 0.19 | +3.22 |
Oceaneering International | OII | 3. jui 2024 | 21.75 | -8.15 |
OceanFirst Financial | OCFC | 3. jui 2024 | 14.48 | -3.79 |
OceanFirst Pref | OCFCP | 3. jui 2024 | 24.75 | +1.02 |
OceanPal | OP | 3. jui 2024 | 2.16 | -3.03 |
Ocugen | OCGN | 3. jui 2024 | 1.70 | -1.73 |
Ocular Therapeutix | OCUL | 3. jui 2024 | 5.51 | -3.33 |
Oculis | OCS | 3. jui 2024 | 11.70 | -0.51 |
Ocuphire Pharma | OCUP | 3. jui 2024 | 1.68 | 0.00 |
Ocwen Financial | OCN | 3. jui 2024 | 25.31 | +3.26 |
Oddity Tech | ODD | 3. jui 2024 | 36.27 | +1.00 |
Odyssey Marine Exploration | OMEX | 3. jui 2024 | 4.97 | +0.40 |
Offerpad Solutions A | OPAD | 3. jui 2024 | 4.94 | +1.86 |
Office Properties | OPI | 3. jui 2024 | 2.29 | 0.00 |
OFG Bancorp | OFG | 3. jui 2024 | 36.42 | -1.99 |
OFS Capital | OFS | 3. jui 2024 | 9.82 | +0.31 |
OFS Credit | OCCI | 3. jui 2024 | 7.50 | +1.21 |
OFS Credit C Pref | OCCIO | 3. jui 2024 | 24.10 | -0.25 |
OFS Credit E Pref | OCCIN | 3. jui 2024 | 23.25 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.